Vitak, Maastricht University
Innovative Medical Devices
Innovation & Research
MGP Center
Human Trial Center: ICHIS
Education
Measurements & Resources

2013

 

  1. Dalmeijer, G.W., van der Schouw, Y.T., Vermeer, C., Magdeleyns, E.J., Schurgers, L.J., Beulens, J.W.J. Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women. J. Nutr. Biochem. 24 (2013) 624-628.

  2. Boraldi, F., Annovi, G., Vermeer, C., Schurgers, L.J., Trenti, T., Tiozzo, R., Guerra, D., Quaglino, D. Matrix Gla Protein and alkaline phosphatase are differently modulated in human dermal fibroblasts of PXE patients and controls. J. Invest. Dermatol. 133 (2013) 946-954.

  3. Theuwissen, E., Teunissen, K.J. Spronk, H.M., Hamulyák, K., Ten Cate, H., Shearer, M.J., Vermeer, C., Schurgers, LJ. Effect of low-dose vitamin K2 intake on the stability of oral anticoagulant treatment: dose-response relationship in healthy volunteers. J. Thromb. Haemostas. 11 (2013) 1085-1092.

  4. Engelen, L., Ferreira, I., Stehouwer, C.D., Boutouyrie, P., Laurent, S., Boutouyrie, P., Laurent, S., Jouven, X., Empana, J.P., Bozec, E., Simon, T., Pannier, B., Mattace-Raso, F.U., Hofman, A., Franco, O.H., Kavousi, M., van Rooij, F.J., Witteman, J., Riezschel, E., Vermeersch, S., Segers, P., Van Bortel, L., De Bacquer, D., Van Daele, C., De Buyzere, M., Bots, M.L., van der Schouw, Y.T., Grobbee, D.E., Uiterwaal, C.S., Evelein, A., van der Graaf, Y., Visseren, F.L., Stehouwer, C., Fewrreira, I., Dekker, J., Nijpels, G., Twisk, J., Smulders, Y., Schalkwijk, C., van Greevenbroek, M., van der Kallen, C., van de Laar, R., Feskens, E., Staessen, J., Thijs, L., Kouznetsova, T., Jin, Y, Liu, Y., Benetos, A., Labat, C., Lacolley, P., Wang, J., Li, Y., Fischer, J., Terris, D., Jarczok, M., Thole, M., Heuten, H., Govaerts, I., Ennekens, G., Vrints, C., Ryliskyte, L. Laucevicius, A., Ryliskiene, K., Kuzmickiene, J., Bianchini, E., Ghiadoni, L., Bruno, R.M., Cartoni, G., Taddei, S., Tolezani, E.C., Hong, V., Bortolotto, H., Vermeer, C., Braam, L., Knapen, M., Drummen, N., Rimoldi, S.F., Stucki, F., Hutter, D., Rexhaj, E., Faita, F., Sartoni, C., Scherrer, U., Allemann, Y., Delahousse, M., Karras, A., Giannettasio, C., Cesana, F., Nava, S., Maloberti, A., Kollai, M., Pintér, A., Horváth, T., Narkiewicz, K., Szyndler, A., Hoffmann, M., Nowak, R., Polonis, K., Thuillez, C., Joannidès, R., Bellien, J., Angel, K., Atar, D., Filipovsky, J., Agharazii, M., Briet, M. Reference intervals for common carotid intima-media thickness measured with echotracking – relation with risk factors. Eur. Heart J., 34 (2013) 2368-2380.

  5. Knapen, M.H.J., Drummen, N.E., Smit, E., Vermeer, C., Theuwissen, E. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos. Int. 24 (2013) 2499-2507.

  6. Crăciun, A.M., Vermeer, C. Apolipoprotein E genotype may influence urinary gammacarboxyglutamate (Gla) concentrations in young individuals. Gen. Physiol. Biophys. 32 (2013) 303-310.

  7. Boraldi, F., Garcia-Fernandez, M.I., Paolinelli-deVincenzi, C., Annovi, G., Schurgers, L., Vermeer, C., Cianciulli, P., Ronchetti, I., Quaglino, D. Ectopic calcifications in beta-thalassemia patients are associated to increased oxidative stress and lower MGP carboxylation. BBA - Molecular Basis of Disease 1832 (2013) 2077-2084.

  8. Beulens, J.W.J., Booth, S.L., van den Heuvel, E., Stoecklin, E., Vermeer, C. The role of menaquinones (vitamin K2) in human health. Brit. J. Nutr. 110 (2013) 1357-1368.

  9. Krüger, T., Oelenberg, S., Schurgers, L., van de Sandt, A., Boor, P., Schlieper, G.R., Brandenburg, V., Fekete, B.C., Veulemans, V., Schafer, C., Ketteler, M., Merx, M.W., Vermeer, C., Jahnen-Dechent, W., Floege, J., Westenfeld, R. Warfarin induces cardiovascular damage in mice. Arterioscler. Thromb. Vasc. Biol. 33 (2013) 2618-2624.

  10. Dalmeijer, G.W., van der Schouw, Y.T., Vermeer, C., Magdeleyns, E.,Velthuis, B.K., de Jong, P.A., Elias, S.G., Beulens, J.W.J. Circulating species of matrix Gla protein and the risk of vascular calcification in healthy women. Int. J. Cardiol 169 (2013) e168-e170.

  11. Dalmeijer, G.W., van der Schouw, Y.T., Magdeleyns, E., Vermeer, C., Verschuren, W.M.M., de Boer, J.M.A., Beulens, J.W.J. Matrix Gla Protein species and risk of cardiovascular events in type 2 diabetes patients. Diabetes Care 36 (2013) 3766-3771.

  12. Theuwissen, E., Badmaev, V., Vermeer, C. Calcium intake and cardiovascular disease mortality: is there a critical role for vitamin K? JAMA Internal Medicine 173 (2013) 1841.

  13. Qureshi, T.M., Vermeer, C., Vegarud, G.E., Abrahamsen, R.K., Skeie, S. Biogenic amines and vitamin K contents in the Norwegian autochthonous cheese Gamalost during ripening. Dairy Sci. & Technol. 93 (2013) 303-314.

  14. Caluwé, R., Vandecasteele, S., Van Vlem, B., Vermeer, De Vriese, A. Vitamin K2 supplementation in hemodialysis patients: a randomized dosefinding study. Nephrol. Dial. Transpl. epub

  15. Van den Heuvel, E.G.H.M., van Schoor, N.M., Deeg, D.J.H., Vermeer, C., Magdeleyns, E.J.P., Lips, P., den Heijer, M. Circulating uncarboxylated Matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease. Maturitas epub

  16. Theuwissen, E., Magdeleyns, E.J., Braam, L.A.J.L.M., Teunissen, K.J., Knapen, M.H.J., Binnekamp, I.A.G., van Summeren, M.J.H., Vermeer, C. Vitamin K status in healthy volunteers. Food Funct. epub


    Published patents:

    - Quinlan, P.T., Vermeer. C. Vitamin containing product. US Patent No. 8 354 129. Jan 15, 2013.

    - Vermeer C. Use of vitamin K for weight maintenance and weight control. US patent No 2013-0267606-A1. Oct 10, 2013.


    - Vermeer, C., de Borst, M. Use of vitamin K to decrease allograft failure and patient mortality after organ transplantation. WO2013/182578-A1. Dec 12, 2013.


    - Vermeer, C., de Borst, M. New biomarkers to estimate the risk of allograft failure and patient mortality after organ transplantation. WO 2013/182579-A1. Dec 12, 2013.